Complete Guide,vasoactive intestinal peptide

Vasoactive intestinal peptide (VIP), also known as vasoactive intestinal polypeptide, is a peptide hormone that plays a crucial role in various physiological processes within the human body. Its presence and concentration in bodily fluids, particularly in vasoactive intestinal peptide levels, can offer significant insights into a person's health status. This article delves into the significance of measuring vasoactive intestinal peptide levels, exploring what these levels indicate, how they are measured, and their association with various medical conditions.

What is Vasoactive Intestinal Peptide?

Vasoactive intestinal peptide is a neuropeptide found in the central and peripheral nervous systems, as well as in neurons of the gastrointestinal system. It functions as a hormone and neurotransmitter, influencing a wide range of bodily functions including smooth muscle relaxation, vasodilation, pancreatic and intestinal secretion, and even playing a role in immune responses and inflammation. Its name aptly describes its primary actions: it is vasoactive, meaning it affects blood vessels, and it is active in the intestine.

Why Measure Vasoactive Intestinal Peptide Levels?

Measuring vasoactive intestinal peptide levels is primarily used to measure the VIP level in the blood to aid in the diagnosis of specific medical conditions. The most significant application of this test is in the identification of VIPomas.

VIPomas and Elevated VIP Levels

A VIPoma is an extremely rare neuroendocrine tumor, often originating in the pancreas or small intestine, that excessively secretes vasoactive intestinal peptide. When a VIPoma is present, it leads to dramatically elevated vasoactive intestinal peptide levels in the blood. This hypersecretion is the hallmark of a condition known as Verner-Morrison's syndrome, characterized by profuse watery diarrhea, hypokalemia (low potassium levels), and gastric acid hyposecretion.

Diagnosing a VIPoma often involves documenting elevated vasoactive intestinal polypeptide concentration. For instance, a fasting plasma VIP level that is two to ten times the upper limit of the normal range, with values greater than 203 pg/mL (60 pmol/L), is highly suggestive of a VIPoma. Some sources indicate that values >75 pg/mL may suggest the presence of an enteropancreatic tumor causing hypersecretion of vasoactive intestinal polypeptide, with values >200 pg/mL being more definitive.

Other Conditions Associated with VIP Levels

While VIPomas are the most common cause of significantly elevated vasoactive intestinal peptide levels, other conditions can also influence these levels:

* Neuroendocrine Tumors: Beyond VIPomas, other neurogenic tumors can sometimes lead to elevated VIP-serum levels.

* Hepatic Cirrhosis: In some cases, advanced liver disease can be associated with altered VIP levels.

* Inflammatory Bowel Disease (IBD): Research suggests that VIP plasma levels may change in IBD. Studies have shown reduced VIP plasma levels in mild cases of IBD, but elevated levels in severe cases, suggesting VIP levels could potentially be a diagnostic tool for IBD prognosis.

* Pancreatic Cancer and Colonic Adenocarcinoma: Investigations have explored VIP-serum levels in patients with these cancers, comparing them to healthy controls.

* Anxiety and Depression: Some studies hypothesize that plasma VIP levels might be associated with symptoms of anxiety and depression, as well as with brain volume and resting-state functional connectivity.

* Gastroduodenal Mucosa: Changes in vasoactive intestinal peptide have been observed in the gastroduodenal mucosa of patients with morbid obesity.

Decreased VIP Levels

Conversely, decreased VIP levels can also be indicative of certain conditions. For example, decreased levels have been found in individuals with cystic fibrosis.

How are Vasoactive Intestinal Peptide Levels Measured?

The Vasoactive Intestinal Polypeptide (VIP) test is the standard method for measuring vasoactive intestinal peptide levels in the blood. This test measures VIP levels in the blood and is often performed using a direct ELISA (Enzyme-Linked Immunosorbent Assay) method.

Sample Collection

Specific protocols are followed for sample collection to ensure accurate results. For example, samples for Vasoactive Intestinal Polypeptide (VIP), Plasma testing are often collected in a prechilled tube.

Reference Ranges

The reference range for vasoactive intestinal peptide levels can vary slightly between laboratories. However, general guidelines exist:

* A common reference range for Vasoactive Intestinal Polypeptide (VIP) is up to 36 pg/ml.

* Another reported range is 0 - 30 pmol/L.

* For diagnostic purposes related to tumors, values greater than 203 pg/mL (60 pmol/L) are considered significant for VIPoma.

* Values >75 pg/mL may indicate the presence of an enteropancreatic